scispace - formally typeset
A

Andrey Korshunov

Researcher at Heidelberg University

Publications -  204
Citations -  23259

Andrey Korshunov is an academic researcher from Heidelberg University. The author has contributed to research in topics: Medulloblastoma & Biology. The author has an hindex of 61, co-authored 159 publications receiving 19174 citations. Previous affiliations of Andrey Korshunov include University Hospital Heidelberg & German Cancer Research Center.

Papers
More filters
Journal ArticleDOI

International network of cancer genome projects

Thomas J. Hudson, +273 more
TL;DR: Systematic studies of more than 25,000 cancer genomes will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.
Journal ArticleDOI

DNA methylation-based classification of central nervous system tumours

David Capper, +171 more
- 22 Mar 2018 - 
TL;DR: This work presents a comprehensive approach for the DNA methylation-based classification of central nervous system tumours across all entities and age groups, and shows that the availability of this method may have a substantial impact on diagnostic precision compared to standard methods.
Journal ArticleDOI

Medulloblastoma Comprises Four Distinct Molecular Variants

TL;DR: The authors' integrative genomics approach to a large cohort of medulloblastomas has identified four disparate subgroups with distinct demographics, clinical presentation, transcriptional profiles, genetic abnormalities, and clinical outcome.
Journal ArticleDOI

Analysis of the IDH1 codon 132 mutation in brain tumors

TL;DR: The very high frequency of IDH1 mutations in WHO grade II astrocytic and oligodendroglial gliomas suggests a role in early tumor development.
Journal ArticleDOI

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

Kristian W. Pajtler, +61 more
- 11 May 2015 - 
TL;DR: The molecular classification proposed herein outperforms the current histopathological classification and thus might serve as a basis for the next World Health Organization classification of CNS tumors.